Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEPO-Fc in renal anemia hemodialysis patients (Phase II)
CTR20170832Phase 2Completed
- Sponsor
- Shanghai Meiye Biotechnology
- Start
- Aug 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin-Fc fusion protein in anaemia, sponsored by Shanghai Meiye Biotechnology. Started Aug 2017; status: completed.
02
Drugs
erythropoietin-Fc fusion protein
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20170832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170832.